Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00231517 |
Date of registration:
|
03/10/2005 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa
|
Scientific title:
|
|
Date of first enrolment:
|
October 2005 |
Target sample size:
|
|
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00231517 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
United Kingdom
| | | | | | | |
Contacts
|
Name:
|
Richard Howard, Prof |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Institute of Child Health |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- children under 18 years epidermolysis wounds requiring dressing changes
Age minimum:
4 Years
Age maximum:
18 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Epidermylosis Bullosa
|
Intervention(s)
|
Drug: morphine sulphate in intrasite gel
|
Drug: topical opiod
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|